Tulane University School of Medicine
Section Chief of Infectious Diseases, John W. Deming Department of Medicine, Tul
Tulane University School of Medicine, New Orleans, Louisiana, United States, 70123
Section Chief of Infectious Diseases, John W. Deming Department of Medicine, Tulane University School of Medicine
Join to apply for the Section Chief of Infectious Diseases in the John W. Deming Department of Medicine at Tulane University School of Medicine. The role offers a unique opportunity in a renowned academic setting with a rich history in infectious diseases research and impact on public health. The Chief reports to the Chair of the Department.
Tulane School of Medicine, founded in 1834, was created to respond to the yellow fever epidemic. It has become a leading center for infectious diseases, research, and pandemic preparedness.
Key Responsibilities
Leadership and Administration
Clinical Excellence
Research and Innovation
Education and Training
Community Engagement
Research Portfolio The Section’s research portfolio spans a broad-based community with global reach, including COVID‑19 vaccine trials, HIV therapeutic trials, and prevention, diagnosis, treatment of dengue, Zika, and other vector‑borne diseases.
Significant Research Collaborations
Tulane National Biomedical Research Center – One of seven NIH‑funded primate research centers focused on infectious disease research.
School of Medicine, Department Microbiology and Immunology – Ranked 33rd out of 96 Departments in the U.S.
School of Public Health and Tropical Medicine – Internationally recognized leaders in tuberculosis and vector‑borne diseases.
Tulane’s Center for Translational Research in Infection and Immunology – Core mission to reduce disease burden through transformative research.
Established Biosafety Level 3 Laboratories – Multiple BSL‑3 facilities including a regional biocontainment laboratory.
Seniority level Executive
Employment type Full‑time
Job function Other
Industry Higher Education
#J-18808-Ljbffr
Tulane School of Medicine, founded in 1834, was created to respond to the yellow fever epidemic. It has become a leading center for infectious diseases, research, and pandemic preparedness.
Key Responsibilities
Leadership and Administration
Clinical Excellence
Research and Innovation
Education and Training
Community Engagement
Research Portfolio The Section’s research portfolio spans a broad-based community with global reach, including COVID‑19 vaccine trials, HIV therapeutic trials, and prevention, diagnosis, treatment of dengue, Zika, and other vector‑borne diseases.
Significant Research Collaborations
Tulane National Biomedical Research Center – One of seven NIH‑funded primate research centers focused on infectious disease research.
School of Medicine, Department Microbiology and Immunology – Ranked 33rd out of 96 Departments in the U.S.
School of Public Health and Tropical Medicine – Internationally recognized leaders in tuberculosis and vector‑borne diseases.
Tulane’s Center for Translational Research in Infection and Immunology – Core mission to reduce disease burden through transformative research.
Established Biosafety Level 3 Laboratories – Multiple BSL‑3 facilities including a regional biocontainment laboratory.
Seniority level Executive
Employment type Full‑time
Job function Other
Industry Higher Education
#J-18808-Ljbffr